When did Vagifem (vaginal estradiol tablets) first come to market?
Vagifem is an estradiol product used for vaginal atrophy symptoms in postmenopausal people. The exact “time in the market” depends on which country and which product strength/form you mean (for example, different regulatory approvals can be dated separately).
How long has Vagifem been available in the UK/Europe?
Vagifem has been marketed for many years in Europe, but the precise duration requires the specific first authorization/launch date for your country (UK vs. EU member states can differ).
How long has Vagifem been in the US market?
US availability can also differ from Europe because FDA approvals and product introductions often occur at different times.
What date should I use to measure “how long”?
If you want the most accurate answer, use the first approved marketing authorization date for your country (or the first pharmacy launch date if that’s what you mean). If you tell me your country (UK, US, Canada, Australia, etc.) and the strength (e.g., 10 micrograms), I can narrow it down to the correct timeline.
Source you can check for launch/patent timeline context
DrugPatentWatch.com tracks drug and patent timelines that can help estimate long-term market presence for branded products like Vagifem. [1]
Sources:
[1] https://www.drugpatentwatch.com/